ErbB receptors: new insights on mechanisms and biology.

@article{Linggi2006ErbBRN,
  title={ErbB receptors: new insights on mechanisms and biology.},
  author={B. Linggi and G. Carpenter},
  journal={Trends in cell biology},
  year={2006},
  volume={16 12},
  pages={
          649-56
        }
}
The ErbB family of four receptor tyrosine kinases occupies a central role in a wide variety of biological processes from neuronal development to breast cancer. New information continues to expand their biologic significance and to unravel the molecular mechanisms that underlie the signaling capacity of these receptors. Here, we review several aspects of ErbB receptor physiology for which new and significant information is available. These include ligand-dependent receptor dimerization and… Expand
The epidermal growth factor receptor family: Biology driving targeted therapeutics
TLDR
The biology of ErbB receptors is reviewed, including their structure, signaling, regulation, and roles in development and disease, then their increasing roles as targets for cancer therapy are briefly touched on. Expand
Mechanisms of ErbB receptor negative regulation and relevance in cancer.
TLDR
How loss or suppression of ErbB negative regulators may contribute to tumor development is described, and how restoration or augmentation of these pathways may represent a novel avenue for the development ofErbB-targeted therapies. Expand
Transmembrane helix-helix interactions involved in ErbB receptor signaling
TLDR
This review focuses on the function of the ErbB family of receptor tyrosine kinases with a special emphasis on the role of the transmembrane domain and on the mechanisms underlying regulated and deregulated signaling. Expand
Cell and molecular biology of epidermal growth factor receptor.
TLDR
This chapter is an update on EGFR-mediated signaling, and describes some recent developments in the regulation of receptor biology. Expand
The ERBB3 receptor in cancer and cancer gene therapy
TLDR
A wide and centrally important role for ERBB3 in cancer is becoming increasingly apparent and small inhibitory RNA to ERBB2 or AKT is showing promise as a therapeutic approach to treatment of lung adenocarcinoma. Expand
Targeting the calmodulin-regulated ErbB/Grb7 signaling axis in cancer therapy.
TLDR
The regulation exerted by the calcium-receptor protein calmodulin (CaM) on signaling routes involving the family of ErbB receptors - highlighting the epidermal growth factor receptor (EGFR/ErbB1) and ErbbB2 - and the adaptor protein Grb7, a downstream signaling component of these receptors are described. Expand
Experimental and Computational Analysis of Epidermal Growth Factor Receptor Pathway Phosphorylation Dynamics
The epidermal growth factor receptor (EGFR, also known as ErbB1) is a prototypical receptor tyrosine kinase (RTK) that activates multi-kinase phosphorylation cascades to regulate diverse cellularExpand
Nuclear Translocation of the Epidermal Growth Factor Receptor Family Membrane Tyrosine Kinase Receptors
TLDR
An integrated picture of the RTK-centered signaling transduction network extending from the membrane-cytoplasm boundary to the nuclear compartment is looming in the foreseeable horizon for clinical application. Expand
Mechanisms of Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3) Action in Human Neoplasia.
TLDR
The unique structural and functional features of ER BB3 are discussed and how this information is being used to develop effective new therapeutic agents that target ERBB3 in human cancers are discussed. Expand
Cell‐Surface Receptors: Structure, Activation, and Signaling
TLDR
This article focuses on the three major types of cell-surface receptors: catalytic tyrosine kinase receptors, cytokine receptors, and seven-transmembrane receptors. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 79 REFERENCES
Negative regulation of ErbB family receptor tyrosine kinases
TLDR
It will be of interest to determine the extent to which tumour cells suppress these pathways to promote their progression, and whether restoration of endogenous receptor-negative regulatory pathways may be exploited for therapeutic benefit. Expand
Nuclear localization and possible functions of receptor tyrosine kinases.
  • G. Carpenter
  • Biology, Medicine
  • Current opinion in cell biology
  • 2003
TLDR
Tentative evidence suggests that nuclear localization of receptor tyrosine kinases is growth-factor-dependent and tentative evidence suggests a role in transcription. Expand
Untangling the ErbB signalling network
When epidermal growth factor and its relatives bind the ErbB family of receptors, they trigger a rich network of signalling pathways, culminating in responses ranging from cell division to death,Expand
A putative mechanism for downregulation of the catalytic activity of the EGF receptor via direct contact between its kinase and C-terminal domains.
TLDR
The computational analyses suggest that direct contact between the kinase and a segment from the C-terminal regulatory domains inhibits enzymatic activity in EGFR, providing an explanation at the molecular level for the effects of several cancer-causing EGFR mutations. Expand
ErbB4 Signaling During Breast and Neural Development: Novel Genetic Models Reveal Unique ErbB4 Activities
TLDR
The progress made studying these genetic models in understanding the physiological roles of ErbB4 with a focus on the mammary gland and the nervous system is discussed. Expand
Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth.
TLDR
A novel transforming mechanism for the ErbB4 receptor in human breast cancer is suggested that is specific for a single receptor isoform and depends on proteinase cleavage and kinase activity but not ligand activation of the receptor. Expand
The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells.
TLDR
It is proposed that ligand-induced mitochondrial accumulation of 4ICD represents a unique mechanism of action for transmembrane receptors, directly coupling a cell surface signal to the tumor cell mitochondrial apoptotic pathway. Expand
Coregulation of estrogen receptor by ERBB4/HER4 establishes a growth-promoting autocrine signal in breast tumor cells.
TLDR
The results indicate that ERBB4 is a unique coregulator of ER, directly coupling extranuclear and nuclear estrogen actions in breast cancer and proposes that the contribution of an autocrine ER BB4/ER signaling pathway to tumor growth and therapeutic response should be considered when managing patients with ER-positive breast cancer. Expand
Epidermal growth factor receptor: mechanisms of activation and signalling.
TLDR
The structure and function of the EGFR is reviewed, from ligand binding to the initiation of intracellular signalling pathways that lead to changes in the biochemical state of the cell. Expand
EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization.
TLDR
The structure reveals an autoinhibited configuration, where the dimerization interface recently identified in activated sEGFR structures is completely occluded by intramolecular interactions, which contrasts starkly with other RTK activation mechanisms and suggests new approaches for designing ErbB receptor antagonists. Expand
...
1
2
3
4
5
...